COMMUNIQUÉS West-GlobeNewswire

Omada Health to Host its First Investor Day on September 10, 2026
15/07/2026
SAN FRANCISCO, July 15, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will host its first Investor Day on Thursday [...]
Biogen Appoints Michael J. Parini as Chief Legal Officer
15/07/2026
CAMBRIDGE, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the appointment of Michael J. Parini as Chief Legal Officer, effective August 3, 2026. Parini will serve as a member of [...]
BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
15/07/2026
MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, [...]
The Coalition for Physician & APP Well-Being Launches “The Initiative Intelligence Guide” to Help Health Systems Better Evaluate Workforce, Retention, and Operational Initiatives
15/07/2026
The Coalition and American Hospital Association, AdventHealth, Atalan, and Providence’s Well Being Trust collaborate on practical framework for healthcare initiative evaluation ALTAMONTE SPRINGS, Fla., July 15, 2026 ( [...]
Sienna Announces July Dividend
15/07/2026
MARKHAM, Ontario, July 15, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Belite Bio to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
15/07/2026
SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative [...]
SBC Medical to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:30 a.m. ET
15/07/2026
IRVINE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range [...]
SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome
15/07/2026
TEL AVIV, Israel, July 15, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage [...]
Persephoni Backs SelSym Biotech to Bring Blood-Type-Agnostic Bleeding Control to the Point of Injury
15/07/2026
SelSym Biotech joins Persephoni to advance the first shelf-stable, blood-type agnostic hemostatic therapy designed for use at the point of injury, where no such option exists today RESEARCH TRIANGLE PARK, N.C., July 15 [...]
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
15/07/2026
Data show clade IIb from 2022 outbreak is 100 to 100,000-fold less virulent than clade IIa from 2003 outbreak Three new models for investigating mpox infection and pathogenesis identified Tonix is advancing TNX-801, a [...]
Alembic Therapeutics LLC Announces Exclusive U.S. Distribution of NUVESSA® (metronidazole vaginal gel 1.3%)
15/07/2026
BEDMINSTER, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics LLC today announced that it has become the exclusive U.S. distributor of NUVESSA® (metronidazole vaginal gel 1.3%), an FDA-approved prescription [...]
New FDA-Cleared Single-Step Immunoblot IGeneX Tests Improve Early Detection of Lyme Disease, Study Finds
15/07/2026
Study published in Microbiology Spectrum shows single-step tests outperform conventional two-tier testing in early-stage Lyme disease MILPITAS, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- IGeneX, Inc ., a specialty [...]
Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion
15/07/2026
Delivered strong Q3 financial results: Generated $31.8 million in total net revenues, $13.4 million in gross profit before fair value adjustments, or 42% of revenues, $8.5 million in adjusted EBITDA 1 , and $5.7 million [...]
Cardiff Oncology Announces $10 Million Registered Direct Offering
15/07/2026
SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF) (the “Company”), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies, today announced [...]
Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman
15/07/2026
The appointment comes as Rectify transitions into a clinical-stage company following the recent initiation of the Phase 1 study of RTY-406, its lead program for hepatobiliary diseases. Rectify is developing oral [...]
Lark Health Partners with Samsung to Bring AI-Powered Health Coach to U.S. Seniors
15/07/2026
Through the integration Samsung users will have access to health coaching and eligible Medicare beneficiaries access to Lark’s proven chronic disease management programs, at no out-of-pocket cost MOUNTAIN VIEW, Calif., [...]
Mixie Technologies, Inc. (OTC: MIXE) Completes Corporate Rebranding and Trading Symbol Change
15/07/2026
Mixie Technologies focuses on acquiring companies and intellectual property built on unique, application-focused technology designed to deliver an advantage to customers, then scales them with AI-driven engineering [...]
Cannara annonce un chiffre d’affaires record au troisième trimestre et une rentabilité soutenue, parallèlement à l’extension de sa distribution nationale et à l’accélération de l’augmentation de ses capacités
15/07/2026
De solides résultats financiers au troisième trimestre : 31,8 millions de dollars en produits totaux, déduction faite des taxes d’accise, une marge brute avant ajustements de la juste valeur de 13,4 millions de dollars [...]
NewcelX Granted Patent in Brazil for NCEL-101 in Type 1 Diabetes, Expanding Global IP Portfolio
15/07/2026
Brazil patent complements U.S. patent portfolio for NCEL-101, strengthening global position in the type 1 diabetes market ZURICH, July 15, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (“NewcelX”; Nasdaq: NCEL), a clinical- [...]

Pages